$2.60
0.155.89%
Last update: Nov 6, 4:26 PM
Eledon Pharmaceuticals Inc (ELDN) Stock Price, Quote, News & History
ELDNNASDAQ
NewcelX submitted an FDA Pre-IND package for NCEL-101 to advance its type 1 diabetes treatment into human trials.
You can purchase shares of Eledon Pharmaceuticals (NASDAQ:ELDN) through any online brokerage.
Other companies in Eledon Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Eledon Pharmaceuticals has a consensus price target of $11.40.
The stock price for Eledon Pharmaceuticals (NASDAQ: ELDN) is $2.605 last updated November 6, 2026 at 4:26 PM EST.
There are no upcoming dividends for Eledon Pharmaceuticals.
Eledon Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Eledon Pharmaceuticals.
Eledon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral...
